Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionlipid transporter activity

ANO5 ABCD1 ABCB1

8.04e-04196193GO:0005319
GeneOntologyMolecularFunctioncarboxylic acid transmembrane transporter activity

SLC16A3 ABCD1 ABCB1

9.41e-04207193GO:0046943
GeneOntologyMolecularFunctionorganic acid transmembrane transporter activity

SLC16A3 ABCD1 ABCB1

9.54e-04208193GO:0005342
GeneOntologyMolecularFunctionABC-type transporter activity

ABCD1 ABCB1

9.82e-0449192GO:0140359
GeneOntologyMolecularFunctionintramembrane lipid transporter activity

ANO5 ABCB1

1.06e-0351192GO:0140303
GeneOntologyMolecularFunctionphospholipid transporter activity

ANO5 ABCB1

2.22e-0374192GO:0005548
GeneOntologyMolecularFunctionorganic anion transmembrane transporter activity

SLC16A3 ABCD1 ABCB1

2.55e-03293193GO:0008514
GeneOntologyMolecularFunctionmonocarboxylic acid transmembrane transporter activity

SLC16A3 ABCD1

3.27e-0390192GO:0008028
GeneOntologyMolecularFunctiontransmembrane transporter activity

SLC16A3 ANO5 ABCD1 ABCB1 TPCN1

4.14e-031180195GO:0022857
GeneOntologyMolecularFunctionATPase-coupled transmembrane transporter activity

ABCD1 ABCB1

4.75e-03109192GO:0042626
GeneOntologyMolecularFunctiontransporter activity

SLC16A3 ANO5 ABCD1 ABCB1 TPCN1

6.04e-031289195GO:0005215
GeneOntologyMolecularFunctionSNARE binding

VTI1B TPCN1

7.30e-03136192GO:0000149
MousePhenodecreased gamma-delta intraepithelial T cell number

GPR18 ABCB1

1.26e-0414172MP:0008351
MousePhenoabnormal gamma-delta intraepithelial T cell morphology

GPR18 ABCB1

1.65e-0416172MP:0008349
MousePhenodecreased mature gamma-delta T cell number

GPR18 ABCB1

1.87e-0417172MP:0008354
MousePhenoabnormal intraepithelial T cell number

GPR18 ABCB1

2.11e-0418172MP:0008895
MousePhenoabnormal tibialis anterior morphology

FLNC ANO5

3.17e-0422172MP:0003083
MousePhenoabnormal intraepithelial T cell morphology

GPR18 ABCB1

3.47e-0423172MP:0008894
MousePhenoabnormal mature gamma-delta T cell morphology

GPR18 ABCB1

3.78e-0424172MP:0008344
DomainIG_FLMN

FLNB FLNC

4.88e-0510202SM00557
DomainFilamin/ABP280_rpt

FLNB FLNC

5.96e-0511202IPR001298
DomainFilamin

FLNB FLNC

5.96e-0511202PF00630
DomainFilamin/ABP280_repeat-like

FLNB FLNC

5.96e-0511202IPR017868
DomainFILAMIN_REPEAT

FLNB FLNC

5.96e-0511202PS50194
DomainACTININ_2

FLNB FLNC

2.72e-0423202PS00020
DomainActinin_actin-bd_CS

FLNB FLNC

2.72e-0423202IPR001589
DomainACTININ_1

FLNB FLNC

2.72e-0423202PS00019
DomainABC_TM1F

ABCD1 ABCB1

4.05e-0428202PS50929
DomainABC1_TM_dom

ABCD1 ABCB1

4.05e-0428202IPR011527
DomainABC_transporter_CS

ABCD1 ABCB1

9.14e-0442202IPR017871
DomainABC_TRANSPORTER_2

ABCD1 ABCB1

1.19e-0348202PS50893
DomainABC_tran

ABCD1 ABCB1

1.19e-0348202PF00005
DomainABC_TRANSPORTER_1

ABCD1 ABCB1

1.24e-0349202PS00211
DomainABC_transporter-like

ABCD1 ABCB1

1.29e-0350202IPR003439
DomainHMG_box

HBP1 CIC

1.45e-0353202PF00505
DomainHMG

HBP1 CIC

1.51e-0354202SM00398
DomainHMG_BOX_2

HBP1 CIC

1.51e-0354202PS50118
Domain-

HBP1 CIC

1.56e-03552021.10.30.10
DomainHMG_box_dom

HBP1 CIC

2.18e-0365202IPR009071
DomainCH

FLNB FLNC

2.18e-0365202SM00033
DomainCH

FLNB FLNC

2.52e-0370202PF00307
Domain-

FLNB FLNC

2.59e-03712021.10.418.10
DomainCH

FLNB FLNC

2.74e-0373202PS50021
DomainCH-domain

FLNB FLNC

2.88e-0375202IPR001715
DomainIg_E-set

FLNB FLNC

5.47e-03104202IPR014756
DomainAAA+_ATPase

ABCD1 ABCB1

1.02e-02144202IPR003593
DomainAAA

ABCD1 ABCB1

1.02e-02144202SM00382
PathwayWP_NPHP1_DELETION_SYNDROME

FLNB FLNC

7.48e-0511172M48099
Pubmed

The limits of promiscuity: isoform-specific dimerization of filamins.

FLNB FLNC

3.14e-07220212525170
Pubmed

A novel human actin-binding protein homologue that binds to platelet glycoprotein Ibalpha.

FLNB FLNC

3.14e-0722029694715
Pubmed

Filamins as integrators of cell mechanics and signalling.

FLNB FLNC

9.42e-07320211252955
Pubmed

Filamin A and Filamin B are co-expressed within neurons during periods of neuronal migration and can physically interact.

FLNB FLNC

9.42e-07320212393796
Pubmed

Genomic structure and fine mapping of the two human filamin gene paralogues FLNB and FLNC and comparative analysis of the filamin gene family.

FLNB FLNC

9.42e-07320211153914
Pubmed

The SH2-containing inositol polyphosphate 5-phosphatase, SHIP-2, binds filamin and regulates submembraneous actin.

FLNB FLNC

1.88e-06420211739414
Pubmed

Structural interaction and functional regulation of polycystin-2 by filamin.

FLNB FLNC

1.88e-06420222802962
Pubmed

HIV infection of T cells: actin-in and actin-out.

FLNB FLNC

3.14e-06520219366992
Pubmed

Nephrocystin-conserved domains involved in targeting to epithelial cell-cell junctions, interaction with filamins, and establishing cell polarity.

FLNB FLNC

3.14e-06520212006559
Pubmed

Temporal/spatial expression and efflux activity of ABC transporter, P-glycoprotein/Abcb1 isoforms and Bcrp/Abcg2 during early murine development.

ABCD1 ABCB1

3.14e-06520216458078
Pubmed

Filamin B deficiency in mice results in skeletal malformations and impaired microvascular development.

FLNB FLNC

3.14e-06520217360453
Pubmed

The four murine peroxisomal ABC-transporter genes differ in constitutive, inducible and developmental expression.

ABCD1 ABCB1

6.59e-06720210504404
Pubmed

The Z-disc proteins myotilin and FATZ-1 interact with each other and are connected to the sarcolemma via muscle-specific filamins.

FLNB FLNC

6.59e-06720216076904
Pubmed

MEKK4 signaling regulates filamin expression and neuronal migration.

FLNB FLNC

8.78e-06820217145501
Pubmed

Different splice variants of filamin-B affect myogenesis, subcellular distribution, and determine binding to integrin [beta] subunits.

FLNB FLNC

1.13e-05920211807098
Pubmed

The deubiquitinase OTUD1 regulates immunoglobulin production and proteasome inhibitor sensitivity in multiple myeloma.

FLNB FLNC

1.41e-051020236357400
Pubmed

USP19 deubiquitinating enzyme supports cell proliferation by stabilizing KPC1, a ubiquitin ligase for p27Kip1.

FLNB FLNC

1.72e-051120219015242
Pubmed

Mouse endothelial OTUD1 promotes angiotensin II-induced vascular remodeling by deubiquitinating SMAD3.

FLNB FLNC

1.72e-051120236579465
Pubmed

Organization of focal adhesion plaques is disrupted by action of the HIV-1 protease.

FLNB FLNC

4.78e-051820212119179
Pubmed

Quantitative Protein Expression in the Human Retinal Pigment Epithelium: Comparison Between Apical and Basolateral Plasma Membranes With Emphasis on Transporters.

SLC16A3 ABCB1

4.78e-051820231791063
Pubmed

Fine expression profiling of full-length transcripts using a size-unbiased cDNA library prepared with the vector-capping method.

FLNB FLNC

7.21e-052220218487259
Pubmed

CDK7/GRP78 signaling axis contributes to tumor growth and metastasis in osteosarcoma.

MTX1 FLNB FLNC VTI1B

1.32e-0446820436042349
Pubmed

Quantitative study of the interactome of PKCζ involved in the EGF-induced tumor cell chemotaxis.

FLNB FLNC LLGL1

1.55e-0418420323402259
Pubmed

Association study between single-nucleotide polymorphisms in 199 drug-related genes and commonly measured quantitative traits of 752 healthy Japanese subjects.

SULT2B1 ABCD1 ABCB1

1.79e-0419320319343046
Pubmed

Cooperative control of striated muscle mass and metabolism by MuRF1 and MuRF2.

FLNB FLNC

2.54e-044120218157088
Pubmed

Comparative proximity biotinylation implicates the small GTPase RAB18 in sterol mobilization and biosynthesis.

FLNB FLNC ABCD1 VTI1B

2.77e-0456820437774976
Pubmed

Deltex3 inhibits Epithelial Mesenchymal Transition in Papillary Thyroid Carcinoma via promoting ubiquitination of XRCC5 to regulate the AKT signal pathway.

FLNB FLNC

3.20e-044620233403043
Pubmed

Functional proteomics mapping of a human signaling pathway.

FLNB FLNC HBP1 SENP3

3.22e-0459120415231748
Pubmed

TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.

SUGP1 PREPL CIC SENP3

4.30e-0463820431182584
Pubmed

Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells.

SUGP1 SLC16A3 FLNB CIC

5.03e-0466520430457570
Pubmed

A postnatal switch of CELF and MBNL proteins reprograms alternative splicing in the developing heart.

FLNC ANO5

5.45e-046020219075228
Pubmed

The DNA sequence and biology of human chromosome 19.

SUGP1 SULT2B1 CIC

5.54e-0428420315057824
CoexpressionGSE46606_IRF4HIGH_VS_IRF4MID_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_DN

FLNB ABCB1 LLGL1 RASGEF1B

1.42e-05199204M9846
CoexpressionHALLMARK_PEROXISOME

SULT2B1 ABCD1 ABCB1

6.59e-05104203M5949
CoexpressionDAZARD_UV_RESPONSE_CLUSTER_G24

SULT2B1 HBP1

1.51e-0424202M5002
CoexpressionHARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_3DY_POSITIVE

HBP1 CIC VTI1B RASGEF1B

1.55e-04368204M41100
CoexpressionGSE7348_UNSTIM_VS_LPS_STIM_MACROPHAGE_DN

FLNB GPR18 RASGEF1B

2.82e-04170203M6846
CoexpressionTAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP

FLNB GPR18 ABCB1

3.12e-04176203M15588
CoexpressionGSE13547_2H_VS_12_H_ANTI_IGM_STIM_BCELL_DN

SLC16A3 MTX1 FLNB

3.55e-04184203M2982
CoexpressionGSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_0.5H_CD4_TCELL_DN

GPR18 VTI1B RASGEF1B

3.96e-04191203M4180
CoexpressionGSE19374_UNINF_VS_LISTERIA_INFECTED_MACROPHAGE_DN

SLC16A3 ABCB1 TPCN1

4.40e-04198203M7265
CoexpressionGSE17721_LPS_VS_CPG_0.5H_BMDC_UP

MTX1 ABCD1 LLGL1

4.40e-04198203M3982
CoexpressionGSE41867_DAY15_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_UP

MTX1 GPR18 LLGL1

4.47e-04199203M9452
CoexpressionGSE17721_0.5H_VS_8H_CPG_BMDC_DN

HBP1 ABCB1 LLGL1

4.47e-04199203M4127
CoexpressionGSE22886_NAIVE_CD4_TCELL_VS_12H_ACT_TH1_UP

HBP1 CIC GPR18

4.47e-04199203M4521
CoexpressionGSE22025_TGFB1_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_UP

FLNB HBP1 WWC1

4.47e-04199203M8380
CoexpressionGSE27859_DC_VS_CD11C_INT_F480_INT_DC_DN

MTX1 HBP1 TPCN1

4.53e-04200203M8600
CoexpressionGSE339_EX_VIVO_VS_IN_CULTURE_CD8POS_DC_UP

CIC ABCD1 ABCB1

4.53e-04200203M5131
CoexpressionGSE16385_ROSIGLITAZONE_IL4_VS_IFNG_TNF_STIM_MACROPHAGE_UP

HBP1 GPR18 ABCB1

4.53e-04200203M8030
CoexpressionGSE23321_CENTRAL_VS_EFFECTOR_MEMORY_CD8_TCELL_UP

SLC16A3 FLNB ABCB1

4.53e-04200203M8433
CoexpressionGSE17721_4H_VS_24H_POLYIC_BMDC_DN

SUGP1 SENP3 VTI1B

4.53e-04200203M4099
CoexpressionGSE17721_0.5H_VS_8H_CPG_BMDC_UP

SLC16A3 ABCD1 SENP3

4.53e-04200203M4126
CoexpressionGSE17721_POLYIC_VS_CPG_2H_BMDC_UP

SUGP1 MTX1 VTI1B

4.53e-04200203M3937
CoexpressionHALLMARK_ESTROGEN_RESPONSE_EARLY

SULT2B1 FLNB WWC1

4.53e-04200203M5906
CoexpressionGSE42021_CD24HI_VS_CD24INT_TREG_THYMUS_UP

PREPL VTI1B TPCN1

4.53e-04200203M9584
CoexpressionGSE20366_TREG_VS_TCONV_DN

CIC GPR18 ABCB1

4.53e-04200203M4312
CoexpressionLUI_THYROID_CANCER_CLUSTER_2

SLC16A3 WWC1

4.90e-0443202M7343
CoexpressionBHAT_ESR1_TARGETS_NOT_VIA_AKT1_UP

SULT2B1 FLNB WWC1

5.30e-04211203M2230
CoexpressionTABULA_MURIS_SENIS_LIVER_MYELOID_LEUKOCYTE_AGEING

SLC16A3 RASGEF1B

5.61e-0446202MM3755
ToppCellHippocampus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)|Hippocampus / BrainAtlas - Mouse McCarroll V32

SLC16A3 SULT2B1 VTI1B

4.90e-0516120366554f59eaea4ba55a6c6724f9368e24e99c91e9
ToppCellC_02|World / shred on cell type and cluster

FLNB ABCD1 ABCB1

5.27e-05165203a456c2c9ffe8dc91e17cac84ba87b88e016f8e6d
ToppCell367C-Lymphocytic-NK_cells-NK_cell_D3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

SLC16A3 ABCB1 RASGEF1B

5.47e-0516720399db8871c62336bd215efb65e969783d2b6003b0
ToppCellCOPD-Lymphoid-ILC_A|Lymphoid / Disease state, Lineage and Cell class

SLC16A3 FLNB ABCB1

6.07e-051732034a0043b29f8ede5a74bdb38cbf2c70e12b25e130
ToppCellCOVID-19-kidney-Distal_Epi_Doublet_(PCT)|kidney / Disease (COVID-19 only), tissue and cell type

WWC1 ABCB1 RASGEF1B

6.39e-0517620336f77d878a53b30465b0dea8333a3865dba75613
ToppCellChildren_(3_yrs)-Epithelial-club_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor

SULT2B1 FLNB WWC1

7.06e-05182203215c303df42f13597b2c7a95cb157c6bc7aca9a1
ToppCellLV-10._Endothelium_II|World / Chamber and Cluster_Paper

FLNB ABCB1 RASGEF1B

7.65e-051872037876dcb4800c2e54874df3d933efb79307a64a97
ToppCelldroplet-Heart-HEART-1m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FLNC TPCN1 RASGEF1B

8.14e-051912034bfdf44d4402a42530d30c89d94946acdda4321b
ToppCelldroplet-Heart-HEART-1m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FLNC TPCN1 RASGEF1B

8.40e-05193203d0a5f212f8e8a13dbbe3e41df92548ef82eef70b
ToppCelldroplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-skeletal_muscle_satellite_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SLC16A3 FLNC ABCB1

8.40e-051932031aa3ab528605dc7b2fec46e759c9d1ee93d59b11
ToppCell(0)_NK/T_cells-(0)_NK_T_CD8_Cytotoxic|(0)_NK/T_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1)

SLC16A3 ABCB1 RASGEF1B

8.66e-0519520313717c6e42882162445bc1b1445d66efcb68e19d
ToppCell367C-Lymphocytic-NK_cells|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

SLC16A3 ABCB1 RASGEF1B

8.79e-05196203c6fac4ead13834483e780188de7d417e5cf37611
ToppCellfacs-Diaphragm-Limb_Muscle-3m-Mesenchymal-skeletal_muscle_satellite_cell|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FLNC HBP1 ABCB1

8.79e-0519620397ac47daf5bb07fa5dda3976e1ae402750f959b5
ToppCellfacs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-skeletal_muscle_satellite_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FLNC HBP1 ABCB1

8.92e-051972035bc11aff92da2a0aca8473f997fe7a99f3cae75d
ToppCellParenchymal-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

SULT2B1 FLNB WWC1

9.06e-05198203af399569c718f5fd971d73a7926768c9311002a3
ToppCellASK454-Epithelial-Type_2|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq

ANO5 WWC1

1.66e-03136202ff9a5e111993fdb3ac64c5ef269e3460ff994517
ToppCellCOVID-19_Convalescent-PLT_3|World / Disease Group and Platelet Clusters

FLNB WWC1

1.69e-03137202bb54bb81b450462ad521b57e1a07a80ce1678e67
ToppCellfrontal_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_ALM_Cpa6_Gpr88|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

WWC1 RASGEF1B

1.81e-0314220284742a7e35bab09ee1cca80cfe120b613d6aed6a
ToppCell367C-Myeloid-Macrophage-SPP1+_Macrophage_2|Macrophage / Donor, Lineage, Cell class and subclass (all cells)

GPR18 RASGEF1B

1.86e-0314420238ff324366ad5be626e3657c1e33277fc36ddd4c
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-DC-cDC2-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

SLC16A3 RASGEF1B

1.94e-03147202c5913cc351577e54536dd239a33e5f7a5cb79672
ToppCellTransverse-Dendritic_cell-cDC1|Dendritic_cell / Region, Cell class and subclass

FLNB GPR18

2.04e-031512026870f3b5d2bfad849c3203658b5f28f0ae181295
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_MHC-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

ABCD1 RASGEF1B

2.10e-03153202099382241971412f84b6feefb897360a74a41143
ToppCellfacs-Skin-nan-24m-Epithelial-inner_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FLNB ANO5

2.15e-03155202fa2776d258e0420b2895de1008e292ad7725dac0
ToppCellfacs-Diaphragm-Limb_Muscle-24m-Lymphocytic-T_cell|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SULT2B1 GPR18

2.18e-031562020bd32876413f3308f838f266e8c39ea0937ce5b9
ToppCellfacs-Heart-Unknown-3m-Myeloid-monocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ANO5 ABCB1

2.21e-031572028a393eece90fb9a1b7c356736bdb36277261fbd3
ToppCelldroplet-Liver-Hepatocytes-24m-Myeloid-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SLC16A3 GPR18

2.21e-03157202d8e283414a770f05d71f0455d0822e9a9660b115
ToppCelldroplet-Liver-Hepatocytes-24m-Myeloid-myeloid_leukocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SLC16A3 GPR18

2.21e-03157202165e98bf944572cafbc06ef43c9eab7bd6bea1c2
ToppCellfacs-Heart-Unknown-3m-Myeloid|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ANO5 ABCB1

2.21e-031572022ac4695d9e4ca8d4ba19c555e9a1d86ac8f398ab
ToppCellfacs-Heart-Unknown-3m-Myeloid-monocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ANO5 ABCB1

2.21e-031572028d30d8e6fae93afcada6bd68799439335cd65b69
ToppCellfacs-Diaphragm-Limb_Muscle-24m-Lymphocytic-nan|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SULT2B1 GPR18

2.23e-0315820298fd640ef0bd0014b8c38b81bd5160efcf42f23c
ToppCellfacs-Diaphragm-Limb_Muscle-24m-Lymphocytic|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SULT2B1 GPR18

2.23e-031582024d2d69fbb880b5232d7867b4d099d0f047ca9ebe
ToppCellfacs-Brain_Non-Myeloid-Striatum_-18m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SULT2B1 GPR18

2.23e-03158202b1b1e50ddd231dcd10cc8e6bb68b2a5e0bb1450a
ToppCellChildren_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor

SULT2B1 WWC1

2.26e-031592028680b054622f573a82b1625fb93c2d5db81d1034
ToppCellfacs-Large_Intestine-Distal-18m-Epithelial-Enterocyte_(Proximal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ABCB1 TPCN1

2.26e-03159202709b57f992a29878cc899d760d144d36cb5cb280
ToppCellfacs-Liver-Liver_non-hepato/SCs-18m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SULT2B1 GPR18

2.29e-031602021cb6f42b68c9e41e8edae0de8f0d8371c4620b04
ToppCellPND10-Immune-Immune_Myeloid-Granulocytic-Mast|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

SLC16A3 ABCB1

2.29e-031602026393e3d5c5c8176c93aecd89b313bd054a00d474
ToppCellfacs-Brain_Non-Myeloid-Cortex_-18m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GPR18 ABCB1

2.29e-03160202c0f37057ff073c0578c5236ab5b5f4c9fe2d6224
ToppCellClub_cells-Donor_01|World / lung cells shred on cell class, cell subclass, sample id

SULT2B1 WWC1

2.29e-03160202b261a3a49c850d92bc9e04fc3527c752dfe37a1a
ToppCellfacs-Brain_Non-Myeloid-Hippocampus_-18m-Lymphocytic-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GPR18 ABCB1

2.29e-031602023a5a7984d9ffcb0fbada02b95ffd7aca091acf30
ToppCellfacs-Brain_Non-Myeloid-Hippocampus_-18m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GPR18 ABCB1

2.29e-0316020232a105b99fc565c944672f518d6947dcf9ea8832
ToppCellfacs-Brain_Non-Myeloid-Cerebellum_-18m-Lymphocytic-T_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GPR18 ABCB1

2.29e-0316020297c899df1b57fd2bd1867e02bfedf1920c00ad17
ToppCellfacs-Brain_Non-Myeloid-Hippocampus_-18m-Lymphocytic|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GPR18 ABCB1

2.29e-031602029e238e7cb31070a5b9da73b4bfddde54b969b0fd
ToppCellfacs-Liver-Liver_non-hepato/SCs|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SULT2B1 GPR18

2.29e-03160202ebefde92db400cbe68d9ce31545a0308e0afbde1
ToppCellPND10-Immune-Immune_Myeloid-Granulocytic-Mast-Mast_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

SLC16A3 ABCB1

2.29e-031602022065938e944eb99478fd8132c2c03adeaee6d447
ToppCell367C-Lymphocytic-ILC-ILC-1|367C / Donor, Lineage, Cell class and subclass (all cells)

GPR18 ABCB1

2.35e-0316220274cd0de957fdbe527656befd61f67d6814ce9e98
ToppCell343B-Myeloid-Macrophage-SPP1+_Macrophage_3|343B / Donor, Lineage, Cell class and subclass (all cells)

ABCD1 RASGEF1B

2.35e-031622020acb8f7b51bf422d4f4f8e99bd10360163ae4eb7
ToppCellfacs-Large_Intestine-Distal-18m-Epithelial-enterocyte_of_epithelium_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SULT2B1 TPCN1

2.35e-03162202bc63a96ad3ba0b3433e3679d7a005f47709ff384
ToppCell3'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

NPIPB2 GPR18

2.37e-03163202ed7319185c1ec384444309bb8be95691a0c2091c
ToppCell3'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

NPIPB2 GPR18

2.37e-03163202e6213900f56257fe38ac7852351bea0340294be0
ToppCellILEUM-non-inflamed-(2)_B_cell-(2)_Naive_B_cells|(2)_B_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

GPR18 ABCB1

2.37e-031632029add806d706f7170a49b2c2dcc14343e9befd26c
ToppCellDendritic_Cells-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id

SLC16A3 FLNB

2.37e-031632025fff3932c1c259010e3add7a3b2301df2fa37df1
ToppCellfacs-Liver-Liver_non-hepato/SCs_st-18m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PREPL ABCB1

2.37e-03163202a24db9d266a40f3bffe4f18d277bc269791b4560
ToppCell3'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

NPIPB2 GPR18

2.37e-03163202ef35d7ff09aa364734fea7fdaab6260c0a3fbf09
ToppCell10x5'-GI_large-bowel-Lymphocytic_T_CD4-Tfh|GI_large-bowel / Manually curated celltypes from each tissue

HBP1 ANO5

2.37e-031632024104d3b9748b39cb0744c9be76db21bdda566a0d
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

WWC1 ABCB1

2.40e-03164202382e42701779d12a7948690b3be72d06dd75c8b4
ToppCelldroplet-Lung-30m-Hematologic-myeloid-myeloid_dendritic_cell-myeloid_dendritic_type_1|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

FLNB GPR18

2.43e-03165202479962ce1c3d6636ae62b6709635299748653801
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Degenerative_Distal_Convoluted_Tubule_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

CIC RASGEF1B

2.43e-0316520250f1fa7434ebb777e15d5273d1ff41070cff6db3
ToppCell10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

SLC16A3 FLNB

2.46e-03166202c948df4279ff55b0d2739ad08b145c96ef2dbc97
ToppCell3'_v3-GI_small-bowel-Lymphocytic_Invariant-Inducer-like-ILC3|GI_small-bowel / Manually curated celltypes from each tissue

SLC16A3 FLNB

2.46e-03166202773673a5d0430640439845b264740bfbbdad0cb2
ToppCelldroplet-Thymus-nan-3m-Myeloid-B_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ABCD1 RASGEF1B

2.46e-03166202c0af93db981dfd448abc7efcd257f3e5ff066aae
ToppCellControl-Epithelial-Mesothelial|Control / Disease state, Lineage and Cell class

FLNC WWC1

2.46e-031662021ed3788257e14f097862b999f020bfe2a57de52b
ToppCellFetal_29-31_weeks-Endothelial-endothelial_cell_of_vein-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

FLNB ANO5

2.46e-03166202f7926ee266dcbf10df375cd921f1db5a2fa604f8
ToppCellControl-Epithelial-Mesothelial|World / Disease state, Lineage and Cell class

FLNC WWC1

2.46e-0316620232ebaefa6c074b28193fff764ee7c2c0e9357e20
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

SLC16A3 FLNB

2.46e-03166202ce570b768988e30898cf0387c2aa99989631f13f
ToppCellControl-Lymphocytic_B|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

GPR18 RASGEF1B

2.49e-03167202956da82394fd6a9f45fc2031796f12cc889542cd
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

SULT2B1 RASGEF1B

2.49e-031672023edb0570e583bb527165bcd8a4c25a042054043b
ToppCellControl-Lymphocytic_B-B_cells-B-cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

GPR18 RASGEF1B

2.49e-0316720269ed8a4a507190a1a66c4baf1f3e9be21ada39d8
ToppCellControl-Lymphocytic_B-B_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

GPR18 RASGEF1B

2.49e-03167202a15a70d3837b31cc83a2a9e3f1bbfd77a95f2312
ToppCell(3)_DC_plasmacytoid|World / Lung cell shreds - cell class (v4) and cell subclass (v4)

FLNB ABCD1

2.52e-031682028a913db9b2a1a4ff96fb139734a3834e6aa263f1
ToppCell(3)_MNP-(3)_DC_plasmacytoid|(3)_MNP / Lung cell shreds - cell class (v4) and cell subclass (v4)

FLNB ABCD1

2.52e-0316820213c160ea1a19b47d2e7e2dae818c8dcde4e3e377
ToppCellCOVID-19-kidney-PEC|COVID-19 / Disease (COVID-19 only), tissue and cell type

WWC1 ABCB1

2.52e-03168202a086c306be430adf0632ba53e98cd8014d2de330
ToppCelldroplet-Lung-LUNG-30m-Myeloid-Myeloid_Dendritic_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FLNB GPR18

2.52e-031682022c996d09b6a8ccd3c708146eca310b02eafff425
ToppCellfacs-Liver-Liver_non-hepato/SCs-18m-Lymphocytic-NK_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SULT2B1 GPR18

2.55e-031692028028622ff362d70d1002e65a74ade46ea7f1f13f
ToppCellB_cell|World / lung cells shred on cell class, cell subclass, sample id

FLNB GPR18

2.58e-03170202cec4090ba6a9c934d5f6f9e4aa7823f3713319b7
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-NK-NK|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

GPR18 ABCB1

2.58e-031702029a47d03f7eea6299a836a0eb1e7c1252c03f76df
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-NK|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

GPR18 ABCB1

2.58e-031702020aa11d8cb44403b6769860dac2d3b05da6fff79d
ToppCellfacs-Brain_Non-Myeloid-Cerebellum_-18m-Lymphocytic|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GPR18 ABCB1

2.58e-03170202c4f00c1acde1d3b521101e469101d10fd257653e
ToppCellCOVID-19-Heart-CM_+_Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type

FLNC ANO5

2.58e-031702023f15242a1d3e4e9871d9170b2ef05842fb609c29
ToppCelldroplet-Liver-LIVER-NPC-1m-Lymphocytic-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GPR18 TPCN1

2.58e-031702023ad9f950b87ee98f025ab9b4a8ed551e6a9b4764
ToppCelldroplet-Fat-Gat-18m-Lymphocytic-B_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GPR18 RASGEF1B

2.58e-031702025185187ecf26b4c9eaa0c01ad52697ab8d075cc7
ToppCellfacs-Brain_Non-Myeloid-Cerebellum_-18m-Lymphocytic-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GPR18 ABCB1

2.58e-03170202d3c1edaf0190d8927578043c372dba7477e75e14
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-NK-NK-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

GPR18 ABCB1

2.58e-031702024252c0a335762508bd1f8f71c6e78a657d7df125
ToppCell3'-Adult-Distal_Rectal-Epithelial-mature_enterocytic-Colonocyte|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

SLC16A3 ABCB1

2.61e-031712020597339618fb4d416d55c538eceb353218a55002
ToppCellcellseq2-Epithelial-Epithelial_Glandular-Goblet|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

SLC16A3 SULT2B1

2.61e-03171202fe27bf581c75ef33c2848878e51ed16b275a4c8e
ToppCellcellseq2-Epithelial-Epithelial_Glandular-Goblet-Goblet|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

SLC16A3 SULT2B1

2.61e-0317120225c1979e972c959e1ce4c57804f976f53a247ad7
ToppCell3'-Adult-Distal_Rectal-Epithelial-mature_enterocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

SLC16A3 ABCB1

2.61e-031712020de81d12a8000f2c59cdb214e67dc526d18098fe
ToppCellHealthy/Control-NK_CD56bright|World / Disease group and Cell class

FLNB ABCB1

2.61e-0317120279d7efefdae267905af05f3001514b8b6934d86e
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

SLC16A3 RASGEF1B

2.64e-0317220253dbfe1ac658fd94370cf8e745048cb67fda1daf
ToppCellfacs-Marrow-Granulocytes-24m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SULT2B1 FLNB

2.67e-03173202a5b6c3d58f7a8e533330798b81496009a31548af
ToppCellfacs-Marrow-Granulocytes-24m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SULT2B1 FLNB

2.67e-03173202cc094992b8027f4cef38f0fb0b76f0d07210d1e2
ToppCellfacs-Brain_Non-Myeloid-Cerebellum_-18m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GPR18 ABCB1

2.67e-031732026397b3fa72e2621a9a0f27f49446de2d3a30e420
ToppCellILEUM-inflamed-(1)_T_cell-(1)_T_(gd)|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

SLC16A3 FLNB

2.67e-0317320262f2f42f54c9c6941bf888956be40230f92c883e
ToppCellChildren_(3_yrs)-Epithelial-lung_goblet_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor

SULT2B1 FLNB

2.67e-03173202464267a2ff3f5c387b6c9c6fa4dab135a221f448
ToppCellPND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

FLNB LLGL1

2.67e-031732024968712af1cca8c932abd3323631d7dcaffd4a66
ToppCelldroplet-Lung-LUNG-30m-Lymphocytic-Zbtb32+_B|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

WWC1 GPR18

2.70e-0317420228ec25767bbd4fd898738f9f4d2b585dc91b5adf
ToppCellfacs-Brain_Non-Myeloid-Cortex-3m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SULT2B1 GPR18

2.70e-031742026b362b8a934a4fe6a1dd867b7c448cb3fb3ffd6a
ToppCelldroplet-Kidney-nan-3m-Lymphocytic-B_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GPR18 RASGEF1B

2.70e-03174202ce9bdd02dc8eb45ba9c1481619c0089b465e6442
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

SLC16A3 RASGEF1B

2.70e-03174202062e7bd9072ca7ee68e09b1da28af13f1bc60b44
ToppCellPBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_CD56bright-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

FLNB ABCB1

2.73e-031752020ed053aa8353c72ff37fee830672704a3ddc7d85
ToppCellPBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_CD56bright|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

FLNB ABCB1

2.73e-03175202e219b61d6bc078d44ea7d06191d3462654d857a1
DrugICI 182,780; Down 200; 0.01uM; MCF7; HT_HG-U133A

SULT2B1 FLNB WWC1 TPCN1

1.73e-051822041663_DN
DrugRapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A

SUGP1 CIC ABCD1 TPCN1

2.18e-051932045239_DN
DrugRapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A

SLC16A3 SULT2B1 CIC ABCD1

2.18e-051932041667_DN
DrugMethionine sulfoximine (L) [15985-39-4]; Down 200; 22.2uM; MCF7; HT_HG-U133A

SUGP1 SLC16A3 SULT2B1 CIC

2.23e-051942042831_DN
DrugNaringenine [480-41-1]; Up 200; 14.6uM; MCF7; HT_HG-U133A

SULT2B1 FLNB CIC WWC1

2.27e-051952043278_UP
DrugBenzonatate [104-31-4]; Down 200; 6.6uM; MCF7; HT_HG-U133A

FLNB CIC ABCD1 TPCN1

2.32e-051962041679_DN
DrugMeptazinol hydrochloride [59263-76-2]; Down 200; 14.8uM; MCF7; HT_HG-U133A

SLC16A3 CIC ABCD1 SENP3

2.36e-051972044774_DN
DrugMoxisylyte hydrochoride [964-52-3]; Down 200; 12.6uM; HL60; HT_HG-U133A

SUGP1 SLC16A3 ABCD1 SENP3

2.36e-051972041846_DN
DrugMeclocycline sulfosalicylate [73816-42-9]; Down 200; 5.8uM; MCF7; HT_HG-U133A

SUGP1 CIC ABCD1 TPCN1

2.36e-051972043277_DN
DrugArcaine sulfate [14923-17-2]; Down 200; 14.8uM; PC3; HT_HG-U133A

SUGP1 SLC16A3 ABCD1 TPCN1

2.36e-051972046629_DN
DrugCholecalciferol [67-97-0]; Up 200; 10.4uM; HL60; HT_HG-U133A

SUGP1 SLC16A3 FLNC WWC1

2.41e-051982042436_UP
DrugCefadroxil [50370-12-2]; Down 200; 11uM; MCF7; HT_HG-U133A

SUGP1 CIC ABCD1 TPCN1

2.41e-051982043259_DN
DrugMonocrotaline [315-22-0]; Down 200; 12.2uM; MCF7; HT_HG-U133A

SLC16A3 SULT2B1 FLNB ABCD1

2.41e-051982042749_DN
DrugFolic acid [59-30-3]; Down 200; 9uM; PC3; HT_HG-U133A

SULT2B1 ABCD1 SENP3 TPCN1

2.46e-051992045844_DN
DrugRitodrine hydrochloride [23239-51-2]; Down 200; 12.4uM; HL60; HT_HG-U133A

SUGP1 SLC16A3 ABCD1 SENP3

2.46e-051992041280_DN
DrugTetracycline hydrochloride [64-75-5]; Up 200; 8.4uM; HL60; HG-U133A

SUGP1 SULT2B1 PREPL SENP3

2.51e-052002041397_UP
DrugDiazoxide [364-98-7]; Up 200; 17.4uM; HL60; HG-U133A

SUGP1 FLNB WWC1 SENP3

2.51e-052002041368_UP
Drugtert-butylphenol

HBP1 ABCB1

4.01e-0511202CID000006923
DrugManganese

SLC16A3 GPR18 VTI1B ABCB1 TPCN1

4.87e-05480205ctd:D008345
DrugAC1Q5SG4

SUGP1 MTX1 FLNB

1.56e-04121203CID000001129
Drugacebutolol

ABCB1 LLGL1

1.68e-0422202CID000001978
DrugCCT018159

ABCB1 TPCN1

1.68e-0422202CID005327091
Druggamma-aminobutyraldehyde

SULT2B1 ABCD1

2.17e-0425202CID000000118
DrugAC1L1F8K

ABCB1 LLGL1

3.58e-0432202CID000003130
DrugAC1MJ1SO

SLC16A3 ABCB1

3.81e-0433202CID003084042
Drugfluphenazine dihydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A_EA

SUGP1 SLC16A3 HBP1

4.17e-041692031075_UP
DrugAC1NDX9W

MTX1 ABCD1

4.29e-0435202CID004633087
Druglignoceroyl-CoA

ABCD1 ABCB1

5.33e-0439202CID003082227
DrugLY 294002; Down 200; 10uM; MCF7; HT_HG-U133A

SULT2B1 WWC1 SENP3

5.52e-041862036953_DN
Drug17-AAG; Down 200; 1uM; HL60; HT_HG-U133A

SUGP1 PREPL SENP3

5.70e-041882031167_DN
DrugPhenoxybenzamine hydrochloride [63-92-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A

SUGP1 SLC16A3 ABCD1

5.78e-041892035248_DN
DrugAcacetin [480-44-4]; Down 200; 14uM; HL60; HT_HG-U133A

SUGP1 SLC16A3 FLNB

5.87e-041902032189_DN
DrugProchlorperazine dimaleate [84-02-6]; Up 200; 6.6uM; HL60; HT_HG-U133A

SUGP1 FLNB GPR18

5.87e-041902031286_UP
DrugCeforanide [60925-61-3]; Down 200; 7.6uM; MCF7; HT_HG-U133A

SUGP1 CIC ABCD1

5.96e-041912035351_DN
DrugOxalamine citrate salt [1949-20-8]; Down 200; 9.2uM; MCF7; HT_HG-U133A

SUGP1 SLC16A3 TPCN1

5.96e-041912034969_DN
Drugthioridazine hydrochloride; Up 200; 10uM; MCF7; HG-U133A

FLNC HBP1 LLGL1

5.96e-04191203417_UP
DrugClemastine fumarate [14976-57-9]; Up 200; 8.6uM; MCF7; HT_HG-U133A

SUGP1 SLC16A3 HBP1

6.05e-041922037485_UP
DrugCyclobenzaprine hydrochloride [6202-23-9]; Up 200; 12.8uM; HL60; HT_HG-U133A

SUGP1 ABCD1 TPCN1

6.05e-041922031332_UP
DrugLY 294002; Down 200; 10uM; MCF7; HT_HG-U133A

SLC16A3 SULT2B1 SENP3

6.05e-041922035596_DN
DrugEtifenin [63245-28-3]; Down 200; 12.4uM; HL60; HT_HG-U133A

SUGP1 SLC16A3 WWC1

6.15e-041932032477_DN
DrugLY 294002; Down 200; 10uM; MCF7; HT_HG-U133A

SUGP1 SLC16A3 SULT2B1

6.15e-041932031664_DN
Drugrapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA

SUGP1 SLC16A3 HBP1

6.15e-04193203921_UP
Drug2-propylpentanoic acid; Down 200; 200uM; HL60; HT_HG-U133A

SUGP1 SLC16A3 SENP3

6.15e-041932031155_DN
DrugRapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A

SULT2B1 FLNB SENP3

6.15e-041932036967_DN
DrugCimetidine [51481-61-9]; Down 200; 15.8uM; PC3; HG-U133A

SLC16A3 FLNB HBP1

6.24e-041942031884_DN
DrugICI 182,780; Up 200; 0.01uM; MCF7; HT_HG-U133A

SUGP1 HBP1 CIC

6.24e-041942035235_UP
DrugAcetohexamide [968-81-0]; Down 200; 12.4uM; MCF7; HT_HG-U133A

SUGP1 SLC16A3 CIC

6.24e-041942031707_DN
DrugLY294002; Down 200; 10uM; HL60; HG-U133A

SUGP1 SLC16A3 LLGL1

6.24e-04194203361_DN
DrugFenspiride hydrochloride [5053-08-7]; Up 200; 13.4uM; HL60; HG-U133A

SULT2B1 FLNC SENP3

6.24e-041942031422_UP
DrugLactobionic acid [96-82-2]; Down 200; 11.2uM; MCF7; HT_HG-U133A

SUGP1 FLNB ABCD1

6.24e-041942034950_DN
Drugwortmannin from Penicillium funiculosum; Down 200; 0.01uM; MCF7; HT_HG-U133A

SUGP1 SLC16A3 SULT2B1

6.33e-041952036959_DN
DrugHecogenin [467-55-0]; Down 200; 9.2uM; MCF7; HT_HG-U133A

SUGP1 SLC16A3 ABCD1

6.33e-041952033457_DN
Drugwortmannin from Penicillium funiculosum; Down 200; 0.01uM; PC3; HT_HG-U133A

SUGP1 SLC16A3 TPCN1

6.33e-041952031243_DN
DrugNabumetone [42924-53-8]; Down 200; 17.6uM; MCF7; HT_HG-U133A

SUGP1 SLC16A3 WWC1

6.33e-041952035428_DN
Drug2-propylpentanoic acid; Down 200; 200uM; MCF7; HT_HG-U133A

SUGP1 ABCD1 TPCN1

6.33e-041952031639_DN
DrugRapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA

SUGP1 HBP1 TPCN1

6.33e-041952031045_UP
DrugOfloxacin [82419-36-1]; Down 200; 11uM; HL60; HT_HG-U133A

SUGP1 CIC WWC1

6.33e-041952032340_DN
Drughaloperidol; Down 200; 10uM; HL60; HT_HG-U133A

SUGP1 FLNB TPCN1

6.33e-041952031144_DN
DrugProcyclidine hydrochloride [1508-76-5]; Up 200; 12.4uM; MCF7; HT_HG-U133A

SUGP1 ABCD1 TPCN1

6.33e-041952034817_UP
DrugIdazoxan hydrochloride [79944-56-2]; Up 200; 16.6uM; MCF7; HT_HG-U133A

SUGP1 CIC WWC1

6.33e-041952036465_UP
DrugPyrimethamine [58-14-0]; Down 200; 16uM; MCF7; HT_HG-U133A

CIC ABCD1 TPCN1

6.43e-041962034779_DN
DrugDyclonine hydrochloride [536-43-6]; Down 200; 12.2uM; MCF7; HT_HG-U133A

SUGP1 SLC16A3 SULT2B1

6.43e-041962037022_DN
DrugTranexamic acid [1197-18-8]; Down 200; 25.4uM; MCF7; HT_HG-U133A

SUGP1 CIC TPCN1

6.43e-041962032248_DN
DrugFluphenazine dihydrochloride [146-56-5]; Down 200; 7.8uM; MCF7; HT_HG-U133A

SUGP1 SLC16A3 ABCD1

6.43e-041962037234_DN
DrugMevalonic-D, L acid lactone [674-26-0]; Down 200; 30.8uM; HL60; HT_HG-U133A

SUGP1 SLC16A3 WWC1

6.43e-041962032718_DN
DrugIndapamide [26807-65-8]; Down 200; 10.6uM; HL60; HT_HG-U133A

SUGP1 FLNB CIC

6.43e-041962032361_DN
DrugFlavoxate hydrochloride [3717-88-2]; Down 200; 9.4uM; HL60; HT_HG-U133A

SUGP1 SLC16A3 FLNB

6.43e-041962032373_DN
DrugCarisoprodol [78-44-4]; Down 200; 15.4uM; MCF7; HT_HG-U133A

SLC16A3 CIC TPCN1

6.43e-041962033251_DN
DrugIobenguane sulfate; Down 200; 10.8uM; HL60; HG-U133A

PREPL ABCD1 TPCN1

6.43e-041962031729_DN
DrugNaphazoline hydrochloride [550-99-2]; Down 200; 16.2uM; MCF7; HT_HG-U133A

SULT2B1 ABCD1 TPCN1

6.43e-041962034949_DN
DrugBuflomedil hydrochloride [35543-24-9]; Up 200; 11.6uM; HL60; HT_HG-U133A

FLNB ABCD1 SENP3

6.43e-041962031338_UP
DrugProadifen hydrochloride [62-68-0]; Up 200; 10.2uM; PC3; HT_HG-U133A

SUGP1 WWC1 LLGL1

6.43e-041962035807_UP
DrugTubocurarine chloride pentahydrate (+) [6989-98-6]; Up 200; 5.2uM; HL60; HG-U133A

SUGP1 WWC1 SENP3

6.43e-041962031738_UP
Drugbeta- Belladonnine dichloroethylate [191355-47-2]; Down 200; 6uM; MCF7; HT_HG-U133A

SUGP1 CIC TPCN1

6.43e-041962034984_DN
DrugMetrizamide [31112-62-6]; Down 200; 5uM; MCF7; HT_HG-U133A

CIC ABCD1 TPCN1

6.43e-041962033255_DN
DrugHydroxytacrine maleate (R,S) [118909-22-1]; Up 200; 12.2uM; HL60; HT_HG-U133A

SUGP1 SLC16A3 HBP1

6.43e-041962032430_UP
DrugDiethylstilbestrol [56-53-1]; Down 200; 15uM; MCF7; HT_HG-U133A

SUGP1 SLC16A3 CIC

6.43e-041962033429_DN
DrugAntazoline hydrochloride [2508-72-7]; Down 200; 13.2uM; MCF7; HT_HG-U133A

SLC16A3 SULT2B1 ABCD1

6.43e-041962036775_DN
DrugMetyrapone [54-36-4]; Down 200; 17.6uM; HL60; HT_HG-U133A

SUGP1 SLC16A3 FLNB

6.52e-041972033070_DN
DrugMetoprolol-(+,-) (+)-tartrate salt [56392-17-7]; Down 200; 5.8uM; MCF7; HT_HG-U133A

SUGP1 SLC16A3 FLNB

6.52e-041972036106_DN
DrugTrimetazidine dihydrochloride [13171-25-0]; Down 200; 11.8uM; MCF7; HT_HG-U133A

SLC16A3 SULT2B1 SENP3

6.52e-041972035479_DN
DrugDiethylcarbamazine citrate [1642-54-2]; Down 200; 10.2uM; MCF7; HT_HG-U133A

SUGP1 SLC16A3 TPCN1

6.52e-041972037425_DN
DrugMometasone furoate [83919-23-7]; Down 200; 7.6uM; HL60; HG-U133A

FLNB CIC GPR18

6.52e-041972031746_DN
DrugZardaverine [101975-10-4]; Down 200; 15uM; MCF7; HT_HG-U133A

SLC16A3 FLNB ABCD1

6.52e-041972037347_DN
DrugIpratropium bromide [22254-24-6]; Up 200; 9.8uM; PC3; HT_HG-U133A

SUGP1 WWC1 LLGL1

6.52e-041972035823_UP
DrugUrapidil hydrochloride [64887-14-5]; Down 200; 9.4uM; MCF7; HT_HG-U133A

SUGP1 ABCD1 TPCN1

6.52e-041972036455_DN
DrugOrnidazole [16773-42-5]; Up 200; 18.2uM; MCF7; HT_HG-U133A

SLC16A3 ABCD1 LLGL1

6.52e-041972035483_UP
DrugPrazosin hydrochloride [19237-84-4]; Up 200; 9.6uM; MCF7; HT_HG-U133A

SUGP1 SLC16A3 LLGL1

6.52e-041972036475_UP
Drug3-Acetamidocoumarin [779-30-6]; Down 200; 19.6uM; MCF7; HT_HG-U133A

SLC16A3 ABCD1 TPCN1

6.52e-041972037361_DN
DrugMesalamine [89-57-6]; Down 200; 26.2uM; MCF7; HT_HG-U133A

SUGP1 SLC16A3 ABCD1

6.52e-041972033584_DN
DrugClorgyline hydrochloride [17780-75-5]; Down 200; 13uM; HL60; HG-U133A

SUGP1 SLC16A3 CIC

6.52e-041972031604_DN
DrugGlutethimide, para-amino [125-84-8]; Down 200; 17.2uM; MCF7; HT_HG-U133A

SULT2B1 ABCD1 TPCN1

6.52e-041972037463_DN
DrugSB 202190; Down 200; 1uM; MCF7; HT_HG-U133A

SLC16A3 CIC SENP3

6.52e-041972036909_DN
Drugrosiglitazone; Down 200; 10uM; MCF7; HT_HG-U133A

SUGP1 SLC16A3 SULT2B1

6.52e-041972031658_DN
DrugNorgestrel-(-)-D [797-63-7]; Down 200; 12.8uM; MCF7; HT_HG-U133A

SUGP1 ABCD1 SENP3

6.52e-041972033406_DN
DrugTriamterene [396-01-0]; Down 200; 15.8uM; MCF7; HT_HG-U133A

FLNB CIC WWC1

6.52e-041972031697_DN
DrugDoxepin hydrochloride [1229-29-4]; Down 200; 12.6uM; HL60; HT_HG-U133A

SUGP1 FLNB CIC

6.52e-041972032384_DN
Drug5211181; Down 200; 12uM; MCF7; HT_HG-U133A_EA

SUGP1 SLC16A3 ABCD1

6.52e-04197203834_DN
Drugalpha-estradiol; Up 200; 0.01uM; MCF7; HT_HG-U133A_EA

SULT2B1 CIC TPCN1

6.52e-041972031048_UP
DrugEstriol [50-27-1]; Down 200; 13.8uM; HL60; HT_HG-U133A

SUGP1 SLC16A3 ABCD1

6.52e-041972036140_DN
Diseasedistal muscular dystrophy 4 (implicated_via_orthology)

FLNB FLNC

1.31e-063202DOID:0111190 (implicated_via_orthology)
Diseasemyofibrillar myopathy 5 (implicated_via_orthology)

FLNB FLNC

1.31e-063202DOID:0080096 (implicated_via_orthology)
Diseasemyopathy (implicated_via_orthology)

FLNB FLNC

4.83e-0448202DOID:423 (implicated_via_orthology)
Diseasephospholipids in very small VLDL measurement

SUGP1 SULT2B1

5.46e-0451202EFO_0022300
DiseaseMalignant neoplasm of breast

SLC16A3 FLNB CIC ABCB1 LLGL1

6.22e-041074205C0006142
DiseaseColorectal Neoplasms

SULT2B1 FLNC ABCB1

8.29e-04277203C0009404
DiseaseDisproportionate short stature

FLNB ANO5

1.24e-0377202C0878659
Diseasegastric carcinoma

MTX1 NPIPB2

1.65e-0389202EFO_0000178

Protein segments in the cluster

PeptideGeneStartEntry
MPAKRFNLFLRRRLM

ANO5

46

Q75V66
MLYRNYLRSMRRKSF

GPR18

301

Q14330
MMKFRFRRQGADPQR

LLGL1

1

Q15334
KRLRYMVFRSMLRQD

ABCB1

786

P08183
QRIGMARMFYHRPKY

ABCD1

611

P33897
FREKMAFFTRPRMNI

WWC1

1091

Q8IX03
MLNRYFSKRRPMANG

SLC16A3

136

O15427
RMYRKYHQRPTFRQM

FLNB

61

O75369
RMYRKFHPRPNFRQM

FLNC

81

Q14315
FPYDFRDERMMRNLK

RASGEF1B

121

Q0VAM2
RPMNAFMLFAKKYRV

HBP1

436

O60381
FFLPGRMQRQYMERL

MTX1

286

Q13505
EAFDRAYRKQMRGMP

SULT2B1

291

O00204
RRPMNAFMIFSKRHR

CIC

201

Q96RK0
AFRKRMMLAYRFRPN

SUGP1

621

Q8IWZ8
RRRAMRAFRMLLYSK

SENP3

126

Q9H4L4
AYGMDLKMNFRPERR

PREPL

481

Q4J6C6
YMKMFQRAQELRRRA

NPIPB2

196

A6NJ64
RQFEGLMRFYKPRMS

TPCN1

361

Q9ULQ1
LMRFYKPRMSARERY

TPCN1

366

Q9ULQ1
LSFRNPMMSKLRNYR

VTI1B

71

Q9UEU0